Venrock Management VI’s 10x Genomics TXG Stock Holding History

Venrock Management VI’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$47.6M	Hold	2,106,757	–	–	100%	1
2024 Q2	$41M	Hold	2,106,757	–	–	100%	1
2024 Q1	$79.1M	Hold	2,106,757	–	–	100%	1
2023 Q4	$118M	Buy	+2,106,757	New	+$91.7M	100%	1
2021 Q4	$143M	Hold	962,309	–	–	96.17%	1
2021 Q3	$140M	Hold	962,309	–	–	96.01%	1
2021 Q2	$188M	Hold	962,309	–	–	95.08%	1
2021 Q1	$174M	Sell	962,309 -927,188	-49%	-$160M	96.89%	1
2020 Q4	$268M	Sell	1,889,497 -6,296,068	-77%	-$914M	98.23%	1
2020 Q3	$953M	Sell	8,185,565 -1,158,986	-12%	-$122M	99.56%	1
2020 Q2	$835M	Buy	+9,344,551	New	+$728M	96.64%	1

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Venrock Management VI's TXG Position: Q3 2024 in Review

Venrock Management VI held its 10x Genomics (TXG) position steady in Q3 2024 at 2,106,757 shares worth $47.6M. The position accounts for 100% of the portfolio, ranked #1.

Venrock Management VI first reported a position in TXG in Q2 2020 and has held it in 11 quarters since. The position peaked at $953M in Q3 2020. 266 funds tracked by Wall St. Rank hold TXG as of Q3 2024.

Venrock Management VI held 2,106,757 shares of 10x Genomics worth $47.6M as of Q3 2024.
Venrock Management VI left its 10x Genomics share count unchanged in Q3 2024.
10x Genomics made up 100% of Venrock Management VI's portfolio in Q3 2024, its #1 holding.
Venrock Management VI first reported a position in 10x Genomics in Q2 2020 and has held it in 11 quarters since.
Venrock Management VI's 10x Genomics position peaked at $953M in Q3 2020.
266 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2024.

Based on Venrock Management VI's 13F filing for Q3 2024, filed 14 Nov 2024.